Ceremonial groundbreaking kicks off the first construction phase Pharmaceutical service provider advances its expansion with a 50,000 sqm facility Strateg...

Bellberry Human Research Ethics Committee (HREC) approves Neurizon's Phase 1 formulation study supporting development of the NUZ-001 oral liquid formulation and...

Romaciclib combined with venetoclax (VEN) shows encouraging anti-leukemic activity, including durable responses, in patients with relapsed/refractory acute myel...

Eliquis (apixaban) is on course for one of the largest single-asset revenue collapses in pharmaceutical history. Its sales are forecast to fall from $14.4 billio...

Denmark has a strong digital infrastructure, but the implementation and commercialisation of artificial intelligence in Danish companies is lagging behind. A new...

AOP Health, a global pharmaceutical enterprise group focused on integrated therapies for rare diseases and critical care, today announced a strategic partnership...

First investigational inhaled ENaC blocker to deliver clinically relevant and statistically significant change in lung function compared to placebo Inhaled t...

Rapid binder triage, of AI-driven candidate sets, enables early elimination of non-binders ahead of costly downstream workflows Powered by cell-free technolo...

Savers has launched a new nationwide fundraising campaign to support the work of Operation Smile, inviting customers to turn everyday shopping into life-changing...

New US tariff measures and acute geopolitical tensions are reshaping the global pharmaceutical landscape, prompting companies to rethink supply chains and produc...